Left Atrial Appendage Occlusion: Clinical Outcomes according to Device Implantation Depth

Continuous improvement of left atrial appendage occlusion (LAAO) devices has had a positive impact on the safety and efficacy of this technique. However, device related thrombus formation (DRT) is still a major concern because of the associated increased risk of thromboembolic events. Approaching this complication calls for more intense antithrombotic treatments, which in turn involves a higher risk of bleeding. 

Cierre de orejuela de aurícula izquierda: Resultados clínicos según la profundidad del implante del dispositivo

Multiple clinical, anatomical and procedural factors have been shown to increase the risk of DRT. Among the procedural factors, we find implantation depth. However, data on this aspect are limited to small studies and the differences between devices remains unclear. 

The aim of this retrospective and multicenter study was to assess the role of implantation depth in the formation of DRT. 

Primary end point was device implantation depth (proximal or distal) impact on DRT incidence. Secondary end point focused on DRT incidence relative to implantation area or angle between pulmonary vein crest and device surface. In addition, clinical outcomes and complications were collected both during hospitalization and follow-up. DRT diagnosis was made by transesophageal echocardiography or CT, and defined as the presence of thrombi adhered to device atrial surface.

Read also: Degenerative Mitral Regurgitation: Impact on Post-Procedural Gradient.

The sample included 1317 patients of mean age 74.9, mostly men. 56% of patients underwent proximal device implantation while the remaining 44% received distal implantation. There were no significant differences in procedural outcomes between the groups.  

Proximal implantation patients saw low DRT rate, vs distal implantation patients (2.3% vs 12.2%; P < 0.001), regardless of device type. There were no significant differences in secondary end point. At multivariable analysis, distal implantation and single antiplatelet treatment or its absence (HR: 1.62; CI del 95%: 0.99-2.62) resulted indented factors of DRT.

Conclusion

This study showed that LAAO device implantation depth impacts DRT incidence, and that proximal implantation is the preferred strategy for patients undergoing this procedure. 

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Impact of Device Implant Depth After Left Atrial Appendage Occlusion.

Reference: Pedro Cepas-Guillén, MD, PHD et al J Am Coll Cardiol Intv 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...